CH412892A - Verfahren zur Herstellung von neuen Hydrazin-Derivaten - Google Patents

Verfahren zur Herstellung von neuen Hydrazin-Derivaten

Info

Publication number
CH412892A
CH412892A CH1518864A CH1518864A CH412892A CH 412892 A CH412892 A CH 412892A CH 1518864 A CH1518864 A CH 1518864A CH 1518864 A CH1518864 A CH 1518864A CH 412892 A CH412892 A CH 412892A
Authority
CH
Switzerland
Prior art keywords
preparation
hydrazine derivatives
new hydrazine
new
derivatives
Prior art date
Application number
CH1518864A
Other languages
English (en)
Inventor
Ernst Dr Jucker
Adolf Dr Lindenmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL270803D priority Critical patent/NL270803A/xx
Priority to NL123596D priority patent/NL123596C/xx
Priority claimed from CH1254760A external-priority patent/CH396905A/de
Priority to CH1640164A priority patent/CH412893A/de
Priority to CH1518564A priority patent/CH412891A/de
Priority to CH1518664A priority patent/CH414641A/de
Priority to CH1518764A priority patent/CH412895A/de
Priority to CH654761A priority patent/CH418335A/de
Priority to CH1518964A priority patent/CH412898A/de
Priority to CH1518864A priority patent/CH412892A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to GB37295/61A priority patent/GB939468A/en
Priority to DE19611445140 priority patent/DE1445140A1/de
Priority to LU40792A priority patent/LU40792A1/xx
Priority to FR878200A priority patent/FR1448711A/fr
Priority to BR134007/61A priority patent/BR6134007D0/pt
Priority to FR887088A priority patent/FR1748M/fr
Priority to FR909753A priority patent/FR87954E/fr
Priority to DE19641470282 priority patent/DE1470282A1/de
Priority to LU46296A priority patent/LU46296A1/xx
Publication of CH412892A publication Critical patent/CH412892A/de
Priority to US560062A priority patent/US3445573A/en
Priority to US645082A priority patent/US3459756A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/32—Nitrogen atoms acylated with carboxylic or carbonic acids, or their nitrogen or sulfur analogues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CH1518864A 1960-11-09 1961-09-11 Verfahren zur Herstellung von neuen Hydrazin-Derivaten CH412892A (de)

Priority Applications (20)

Application Number Priority Date Filing Date Title
NL270803D NL270803A (de) 1960-11-09
NL123596D NL123596C (de) 1960-11-09
CH1640164A CH412893A (de) 1960-11-09 1960-11-09 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1518564A CH412891A (de) 1960-11-09 1961-06-06 Verfahren zur Herstellung eines neuen Hydrazin-Derivates
CH1518664A CH414641A (de) 1960-11-09 1961-06-06 Verfahren zur Herstellung eines neuen Hydrazin-Derivates
CH1518764A CH412895A (de) 1960-11-09 1961-06-06 Verfahren zur Herstellung eines neuen Hydrazin-Derivates
CH654761A CH418335A (de) 1960-11-09 1961-06-06 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1518964A CH412898A (de) 1960-11-09 1961-09-11 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1518864A CH412892A (de) 1960-11-09 1961-09-11 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
GB37295/61A GB939468A (en) 1960-11-09 1961-10-18 Improvements in or relating to a sulphonamide
FR878200A FR1448711A (fr) 1960-11-09 1961-11-07 Nouveaux dérivés de l'hydrazine et leur préparation
DE19611445140 DE1445140A1 (de) 1960-11-09 1961-11-07 Neue Hydrazin-Derivate und ihre Herstellung
LU40792A LU40792A1 (de) 1960-11-09 1961-11-07
BR134007/61A BR6134007D0 (pt) 1960-11-09 1961-11-08 Processo para a preparacao de novos derivados de hidrazin
FR887088A FR1748M (fr) 1960-11-09 1962-02-06 Médicament a base d'un amide d'acide benzoique substitué.
FR909753A FR87954E (fr) 1960-11-09 1962-09-18 Nouveaux dérivés de l'hydrazine et leur préparation
DE19641470282 DE1470282A1 (de) 1960-11-09 1964-06-10 Verfahren zur Herstellung von heterocyclischen Verbindungen
LU46296A LU46296A1 (de) 1960-11-09 1964-06-11
US560062A US3445573A (en) 1960-11-09 1966-06-24 Pharmaceutical compositions with salidiuretic and reserpine antagonist activity comprising n-(2',6'-dimethyl-piperidyl-(1'))-3-sulfamyl - 4 - chlorobenzoic acid amide
US645082A US3459756A (en) 1960-11-09 1967-04-17 N-(2',6'-dimethyl-piperidyl-(1'))-3-sulfamyl-4-chloro-benzoic acid amide

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH1254760A CH396905A (de) 1960-11-09 1960-11-09 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1354460 1960-12-02
CH654761A CH418335A (de) 1960-11-09 1961-06-06 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1518864A CH412892A (de) 1960-11-09 1961-09-11 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1047461 1961-09-11

Publications (1)

Publication Number Publication Date
CH412892A true CH412892A (de) 1966-05-15

Family

ID=43798563

Family Applications (2)

Application Number Title Priority Date Filing Date
CH654761A CH418335A (de) 1960-11-09 1961-06-06 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1518864A CH412892A (de) 1960-11-09 1961-09-11 Verfahren zur Herstellung von neuen Hydrazin-Derivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH654761A CH418335A (de) 1960-11-09 1961-06-06 Verfahren zur Herstellung von neuen Hydrazin-Derivaten

Country Status (7)

Country Link
US (2) US3445573A (de)
BR (1) BR6134007D0 (de)
CH (2) CH418335A (de)
FR (1) FR1748M (de)
GB (1) GB939468A (de)
LU (1) LU40792A1 (de)
NL (1) NL270803A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1586468A (en) * 1976-10-29 1981-03-18 Anphar Sa Piperidine derivatives
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
EP2986599A1 (de) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamid-derivate zur behandlung von herz-kreislauf-erkrankungen
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043874A (en) * 1960-05-09 1962-07-10 Parke Davis & Co 4-halo-3-sulfamoylbenzoic acid derivatives and methods for producing same
CH430711A (de) * 1963-12-20 1967-02-28 Sandoz Ag Verfahren zur Herstellung von neuen heterocyclischen Verbindungen

Also Published As

Publication number Publication date
BR6134007D0 (pt) 1973-05-31
US3445573A (en) 1969-05-20
FR1748M (fr) 1963-03-25
CH418335A (de) 1966-08-15
GB939468A (en) 1963-10-16
LU40792A1 (de) 1962-05-07
NL270803A (de)
US3459756A (en) 1969-08-05

Similar Documents

Publication Publication Date Title
AT238716B (de) Verfahren zur Herstellung von neuen Derivaten des 7-Oxycumarins
AT239788B (de) Verfahren zur Herstellung von neuen β-Carbolin-carbonsäureamid-Derivaten
CH386446A (de) Verfahren zur Herstellung von neuen Thioxanthen-Derivaten
CH412892A (de) Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH373391A (de) Verfahren zur Herstellung von neuen Pyrazol-Derivaten
CH410960A (de) Verfahren zur Herstellung von Benzazocinderivaten
CH385854A (de) Verfahren zur Herstellung von neuen Iminodibenzylderivaten
CH398590A (de) Verfahren zur Herstellung von neuen Piperidinderivaten
AT244976B (de) Verfahren zur Herstellung von neuen Oxazinderivaten
CH388336A (de) Verfahren zur Herstellung von Hydrazinderivaten
AT252237B (de) Verfahren zur Herstellung von neuen 2-Isoxazolin-5-onen
CH390256A (de) Verfahren zur Herstellung von neuen Carbostyrilderivaten
CH386428A (de) Verfahren zur Herstellung von neuen Iminodibenzylderivaten
AT214939B (de) Verfahren zur Herstellung von neuen 7-Theophyllinderivaten
CH395994A (de) Verfahren zur Herstellung von neuen Piperidinderivaten
CH400170A (de) Verfahren zur Herstellung von 3,5-Pyrazolidindionderivaten
AT241472B (de) Verfahren zur Herstellung von neuen 1-Azathiaxanthenderivaten
AT233141B (de) Verfahren zur Herstellung von neuen Tetrazapolymethinfarbstoffen
AT232004B (de) Verfahren zur Herstellung von neuen Dialkylxanthinderivaten
AT223609B (de) Verfahren zur Herstellung von neuen Derivaten des Dihydro-anthracens
AT211292B (de) Verfahren zur Herstellung von neuen Hydrazinderivaten
CH390262A (de) Verfahren zur Herstellung von neuen Pyridazinabkömmlingen
AT227689B (de) Verfahren zur Herstellung von neuen α-Pyrrolidinoketonen
AT227263B (de) Verfahren zur Herstellung von neuen 2-Pyridyl-indenen
AT221510B (de) Verfahren zur Herstellung von neuen Cyclopropylamiden